Lido Advisors’s Globus Medical GMED Stock Holding History

Lido Advisors’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,561	Closed	-$221K	–	2197
2026 Q1	$221K	Buy	+2,561	New	+$230K	﹤0.01%	1732
2018 Q3	–	Sell	-5,604	Closed	-$282K	–	456
2018 Q2	$282K	Buy	+5,604	New	+$292K	0.03%	321

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Lido Advisors's GMED Position: Q2 2026 in Review

Lido Advisors sold out of Globus Medical (GMED) in Q2 2026, closing a stake of 2,561 shares — an estimated $221K sold.

Lido Advisors first reported a position in GMED in Q2 2018 and held it in 2 quarters. The position peaked at $282K in Q2 2018. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Lido Advisors reported no remaining Globus Medical position as of Q2 2026 after selling out during the quarter.
Lido Advisors sold 2,561 Globus Medical shares in Q2 2026, an estimated $221K.
Lido Advisors first reported a position in Globus Medical in Q2 2018 and held it in 2 quarters.
Lido Advisors's Globus Medical position peaked at $282K in Q2 2018.
599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Lido Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.